RelB regulates Bcl‑xl expression and the irradiation‑induced apoptosis of murine prostate cancer cells

Zhu,Liang; Zhu,Bin; Yang,Luoyan; Zhao,Xiaokun; Jiang,Honhyi; Ma,Fang

doi:10.3892/br.2014.250

RelB regulates Bcl‑xl expression and the irradiation‑induced apoptosis of murine prostate cancer cells

Authors:
- Liang Zhu
- Bin Zhu
- Luoyan Yang
- Xiaokun Zhao
- Honhyi Jiang
- Fang Ma
View Affiliations

Affiliations: Department of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China, Department of Oncology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
Published online on: March 12, 2014 https://doi.org/10.3892/br.2014.250
Pages: 354-358

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Apoptosis in prostate cancer (PCa) induced by ionizing radiation (IR) is believed to play a critical role in radioresistance. Bcl‑xl, an important member of the anti‑apoptotic Bcl‑2 family, has critical roles in tumor progression and development. The aim of the present study was to investigate the association of Bcl‑xl expression and radiosensitivity from murine PCa RM‑1 cells. An adenovirus‑mediated RNA interference technique was employed to inhibit the expression of the RelB gene. RelB proteins were detected upon irradiation following transfection with small interfering (si)RelB, as shown by western blot analysis. The radiosensitivity of the RM‑1 cells was determined by clonogenic assays. The apoptosis of the RM‑1 cells were detected by flow cytometry assay, then quantitative polymerase chain reaction assays were performed to determine the expression level of Bcl‑xl mRNA in the RM‑1 cells. Radiation treatment increased the RelB protein levels from the cytosol and nucleus in the RM‑1 cells. The protein expression levels of RelB in the pLentilox‑sh‑RelB‑transfected RM‑1 cells were significantly lower than in the negative interference group following radiation treatment. The percentage of cells undergoing apoptosis in the siRelB‑RM‑1 group was significantly higher than that in the control group following radiation treatment. Finally, a positive link between Bcl‑xl expression and RelB activity was established in the RM‑1 cells. Inhibition of RelB correlates with a decrease in expression of Bcl‑xl. In conclusion, adenovirus‑mediated siRNA targeting RelB inhibits Bcl‑xl expression, enhances radiosensitivity and regulates the irradiation‑induced apoptosis of the murine PCa RM‑1 cell line.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Xie BX, Zhang H, Yu L, et al: The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP. Asian J Androl. 12:405–414. 2010. View Article : Google Scholar : PubMed/NCBI
3	Alcorn S, Walker AJ, Gandhi N, et al: Molecularly targeted agents as radiosensitizers in cancer therapy - focus on prostate cancer. Int J Mol Sci. 14:14800–14832. 2013. View Article : Google Scholar : PubMed/NCBI
4	Holley AK, Xu Y, St Clair DK and St Clair WH: RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Ann NY Acad Sci. 1201:129–136. 2010. View Article : Google Scholar : PubMed/NCBI
5	Xu Y, Fang F, St Clair DK and St Clair WH: Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism. PLoS One. 7:e329052012.PubMed/NCBI
6	Zhu B, Yang LY, Zhao XK, et al: RNA interference of RelB enhances the radiosensitivity of prostate cancer cell line RM-1 in mice. Zhonghua Nan Ke Xue. 18:595–599. 2012.(In Chinese).
7	Wong WW and Puthalakath H: Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life. 60:390–397. 2008. View Article : Google Scholar : PubMed/NCBI
8	Baud V and Karin M: Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov. 8:33–40. 2009. View Article : Google Scholar : PubMed/NCBI
9	Xu Y, Fang F, Sun Y, et al: RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells. Mol Cancer Ther. 9:803–812. 2010. View Article : Google Scholar : PubMed/NCBI
10	Ribeiro AM, Andrade S, Pinho F, et al: Prostate cancer cell proliferation and angiogenesis in different obese mice models. Int J Exp Pathol. 91:374–386. 2010. View Article : Google Scholar : PubMed/NCBI
11	Zhu HC, Tao T and Liu XH: Construction and identification of mouse RelB siRNA-expressing lentiviral vectors. Sci Res Essays. 6:777–783. 2011.
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
13	Han RQ, Wu M, Chen WQ, et al: Analysis on incidence and mortality of prostate cancer in China during 2003–2007. China Cancer. 21:805–811. 2012.(In Chinese).
14	Dass K, Ahmad A, Azmi AS, Sarkar SH and Sarkar FH: Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev. 34:122–136. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zhang AL and Russell PJ: Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice. Cancer Lett. 233:185–191. 2006. View Article : Google Scholar : PubMed/NCBI
16	Xu Y, Fang F, St Clair DK, et al: SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation. Mol Cancer Ther. 7:2367–2376. 2008. View Article : Google Scholar : PubMed/NCBI
17	Xu Y, Fang F, St Clair DK, et al: Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells. Mol Cancer Ther. 6:2048–2056. 2007. View Article : Google Scholar
18	Josson S, Xu Y, Fang F, et al: RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene. 25:1554–1559. 2006. View Article : Google Scholar : PubMed/NCBI
19	Russo A, Terrasi M, Agnese V, et al: Apoptosis: a relevant tool for anticancer therapy. Ann Oncol. 17(Suppl 7): vii115–vii123. 2006. View Article : Google Scholar : PubMed/NCBI
20	Mineva ND, Rothstein TL, Meyers JA, et al: CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem. 282:17475–17485. 2007. View Article : Google Scholar : PubMed/NCBI
21	Llambi F and Green DR: Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr Opin Genet Dev. 21:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
22	Strik H, Deininger M, Streffer J, et al: BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry. 67:763–768. 1999. View Article : Google Scholar : PubMed/NCBI
23	Li JY, Li YY, Jin W, et al: ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL. J Exp Clin Cancer Res. 31:1022012. View Article : Google Scholar : PubMed/NCBI
24	Yang J, Sun M, Zhang A, et al: Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World J Surg Oncol. 9:1172011. View Article : Google Scholar